844 filings
Page 2 of 43
UPLOAD
ENVB
Enveric Biosciences Inc
16 Jan 24
Letter from SEC
12:00am
S-3
ENVB
Enveric Biosciences Inc
Shelf registration
11 Jan 24
4:43pm
8-K
ENVB
Enveric Biosciences Inc
8 Jan 24
Cost Associated with Exit or Disposal Activities
4:42pm
8-K
ENVB
Enveric Biosciences Inc
3 Jan 24
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
8:05am
8-K
ENVB
Enveric Biosciences Inc
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
8-K
ENVB
Enveric Biosciences Inc
28 Dec 23
Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission
8:05am
8-K
ENVB
Enveric Biosciences Inc
27 Dec 23
Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
8:05am
424B4
ENVB
Enveric Biosciences Inc
6 Dec 23
Prospectus supplement with pricing info
4:00pm
EFFECT
ENVB
Enveric Biosciences Inc
6 Dec 23
Notice of effectiveness
12:15am
8-K
ENVB
Enveric Biosciences Inc
5 Dec 23
Three novel neuroplastic compounds identified with plans to advance one into expedited preclinical development in 2024
8:05am
CORRESP
ENVB
Enveric Biosciences Inc
4 Dec 23
Correspondence with SEC
12:00am
S-1/A
ENVB
Enveric Biosciences Inc
IPO registration (amended)
1 Dec 23
4:31pm
8-K
ENVB
Enveric Biosciences Inc
29 Nov 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
8:18am
8-K
ENVB
Enveric Biosciences Inc
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
UPLOAD
ENVB
Enveric Biosciences Inc
16 Nov 23
Letter from SEC
12:00am
8-K
ENVB
Enveric Biosciences Inc
13 Nov 23
Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results
4:10pm
10-Q
2023 Q3
ENVB
Enveric Biosciences Inc
Quarterly report
13 Nov 23
4:06pm
S-1
ENVB
Enveric Biosciences Inc
IPO registration
7 Nov 23
6:06pm
8-K
ENVB
Enveric Biosciences Inc
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
ENVB
Enveric Biosciences Inc
2 Nov 23
Departure of Directors or Certain Officers
5:29pm